Adalta Ltd has released a press release.
BIO International Convention presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from AdAlta
- AdAlta presentation at Bioshares Biotech Summit
- Indian patent for AD-214
- Inhaled AD-214 preclinical program
- PAC Partners Healthcare Conference - Corporate Presentation
- $1.6M Second Tranche R&D Cash Flow Loan Received
Later from AdAlta
- European Patent for AD-214 granted
- AD-214 program update, cash runway extension
- Quarterly Appendix 4C and Activities Report
- R&D Tax Incentive Refund received
- 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta